Skip to content
Commercial Litigation Woods Lonergan LLP

212.684.2500

Copyright Litigation

MarketAxess Announces Monthly Volume Statistics for September 2017 - GlobeNewswire (press release)

October 3, 2017 - 4:12pm

MarketAxess Announces Monthly Volume Statistics for September 2017
GlobeNewswire (press release)
... ability to protect our intellectual property rights or technology and defend against intellectual property infringement or other claims; our ability to enter into strategic alliances and to acquire other businesses and successfully integrate them ...

and more »

Intellia Therapeutics to Present at October Healthcare Investor Conferences - GlobeNewswire (press release)

October 3, 2017 - 3:35pm

Intellia Therapeutics to Present at October Healthcare Investor Conferences
GlobeNewswire (press release)
Our combination of deep scientific, technical and clinical development experience, along with our leading intellectual property portfolio, puts us in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a ...

and more »

Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares - GlobeNewswire (press release)

October 3, 2017 - 3:02pm

Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares
GlobeNewswire (press release)
... development of RECORLEV and veldoreotide, commercialization expenditures, and for other general corporate purposes, which may include working capital, capital expenditures, acquisition of additional technologies or other forms of intellectual ...

and more »

Everbridge Announces Major Breakthrough in IT Alerting with the Release of Smart Analytics - Cellular News

October 3, 2017 - 12:38pm

Everbridge Announces Major Breakthrough in IT Alerting with the Release of Smart Analytics
Cellular News
... our ability to respond to competitive pressures; potential liability related to privacy and security of personally identifiable information; our ability to protect our intellectual property rights, and the other risks detailed in our risk factors ...

and more »

SIQ Mountain Industries Inc. Announces Closing of Qualifying Transaction - GlobeNewswire (press release)

October 3, 2017 - 8:03am

SIQ Mountain Industries Inc. Announces Closing of Qualifying Transaction
GlobeNewswire (press release)
The closing involved the issuance of 300,000 shares of the Company to Mr. Arcouette, which were issued into escrow and the transfer of intellectual property rights to the snow-bike technology, including patent applications, know-how, design and ...

nanoPrecision Products Achieves AS 9100D Certification Early, One of the First Certified Under New, More Stringent ... - Cellular News

October 3, 2017 - 6:25am

nanoPrecision Products Achieves AS 9100D Certification Early, One of the First Certified Under New, More Stringent ...
Cellular News
... fluidic and other devices. nanoPrecision Products has strong intellectual property in the areas of optical fiber interconnects, packaging, and manufacturing technology, both domestically and internationally. For more information, visit www ...

and more »

Cesca Receives Notice of Allowance for US Patent Application Covering a Novel Method of Cell Separation - GlobeNewswire (press release)

October 3, 2017 - 6:05am

KL Daily

Cesca Receives Notice of Allowance for US Patent Application Covering a Novel Method of Cell Separation
GlobeNewswire (press release)
“This Notice of Allowance further strengthens our intellectual property position as we advance development of our novel CAR-TXpress™ solution for the automated manufacture of CAR-T cells,” said Chris Xu, Cesca's chief executive officer. “CAR-T ...
Cesca Therapeutics Inc. - KOOL - Stock Price Today - ZacksZacks Investment Research

all 65 news articles »

RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea ... - GlobeNewswire (press release)

October 3, 2017 - 6:01am

Weekly Register

RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea ...
GlobeNewswire (press release)
... maintain for intellectual property rights covering its therapeutic candidates and its ability to operate its business without infringing the intellectual property rights of others; (xi) parties from whom the Company licenses its intellectual ...
Redhill Biopharma Ltd. - RDHL - Stock Price Today - ZacksZacks Investment Research

all 58 news articles »

Kirkland & Ellis unveils largest ever City partner promotions round ... - Legal Week

October 3, 2017 - 5:01am

Legal Week

Kirkland & Ellis unveils largest ever City partner promotions round ...
Legal Week
Kirkland & Ellis has promoted 13 London associates to partner, more than double the amount it made up in its City base last year and the largest ever on record.

and more »

Cincinnati Bell Inc. Completes Acquisition of OnX Enterprise Solutions, Creates Hybrid IT Solutions Provider with CBTS - Cellular News

October 2, 2017 - 8:14pm

Cincinnati Bell Inc. Completes Acquisition of OnX Enterprise Solutions, Creates Hybrid IT Solutions Provider with CBTS
Cellular News
... third parties may claim that we are infringing upon their intellectual property, and we could suffer significant litigation or licensing expenses or be prevented from selling products; third parties may infringe upon our intellectual property, and ...

and more »

New Boston Base of Womble Welcomes Three New Hires - The American Lawyer

October 2, 2017 - 6:33pm

The American Lawyer

New Boston Base of Womble Welcomes Three New Hires
The American Lawyer
Womble Carlyle Sandridge & Rice, which by the end of October will become Womble Bond Dickinson following a cross-border union with former alliance partner Bond Dickinson, has brought on a trio of intellectual property partners from McCarter & English ...

Teligent, Inc. Announces FDA Approval of Partnered ANDA for ... - GlobeNewswire (press release)

October 2, 2017 - 12:38pm

Teligent, Inc. Announces FDA Approval of Partnered ANDA for ...
GlobeNewswire (press release)
BUENA, N.J., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today ...

and more »

ASMI Share Buyback Update September 22-29, 2017 Amsterdam ... - GlobeNewswire (press release)

October 2, 2017 - 10:46am

ASMI Share Buyback Update September 22-29, 2017 Amsterdam ...
GlobeNewswire (press release)
ASM International N.V. (Euronext Amsterdam: ASM) reports the following transactions, conducted under ASMI's current share buyback program.

and more »

REGENXBIO Responds to Notification of a Superior Proposal Under Its Merger Agreement With Dimension Therapeutics - GlobeNewswire (press release)

October 2, 2017 - 7:33am

REGENXBIO Responds to Notification of a Superior Proposal Under Its Merger Agreement With Dimension Therapeutics
GlobeNewswire (press release)
... uncertainties, including the timely development and launch of new products, the ability to obtain and maintain regulatory approval of product candidates, the ability to obtain and maintain intellectual property protection for product candidates and ...

and more »

Atossa Genetics Announces Chimeric Antigen Receptor Therapy ... - GlobeNewswire (press release)

October 2, 2017 - 7:01am

Atossa Genetics Announces Chimeric Antigen Receptor Therapy ...
GlobeNewswire (press release)
SEATTLE, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Atossa Genetics (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics ...

and more »

Sanofi Appoints Stefan Oelrich Executive Vice President Diabetes & Cardiovascular - GlobeNewswire (press release)

October 2, 2017 - 6:59am

Sanofi Appoints Stefan Oelrich Executive Vice President Diabetes & Cardiovascular
GlobeNewswire (press release)
... including future clinical data and analysis of existing clinical data relating to the product, including post marketing, unexpected safety, quality or manufacturing issues, competition in general, risks associated with intellectual property and any ...

and more »

CRISPR Therapeutics Announces Promotion of Samarth Kulkarni, Ph.D. to Chief Executive Officer - GlobeNewswire (press release)

October 2, 2017 - 6:31am

CRISPR Therapeutics Announces Promotion of Samarth Kulkarni, Ph.D. to Chief Executive Officer
GlobeNewswire (press release)
... expectations for regulatory approvals to conduct trials or to market products; our ability to obtain and maintain proprietary intellectual property protection on key products and technologies; uncertainties regarding actual or potential legal ...

and more »

Emerald Health Therapeutics Appoints Pharmaceutical Marketing ... - GlobeNewswire (press release)

October 2, 2017 - 6:01am

Emerald Health Therapeutics Appoints Pharmaceutical Marketing ...
GlobeNewswire (press release)
VICTORIA, British Columbia, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (“EHT”) (TSXV:EMH) (OTCQX:EMHTF) is pleased to ...

and more »

BLM takes 33-strong Slater and Gordon team as Australian-listed ... - Legal Week

October 2, 2017 - 4:53am

Legal Week

BLM takes 33-strong Slater and Gordon team as Australian-listed ...
Legal Week
BLM has sealed the hire of 33 lawyers from Slater and Gordon, including 11 partners, following a strategic review of the struggling Australian-listed firm's UK ...

and more »